bis(2-methyl-4-[5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole);4-[4-[3-[2-(1-methylpiperidin-4-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-(trifluoromethyl)-1,3-thiazole;bis(4-[4-[3-(1,3-thiazol-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)

C131H164F3N27O3S6 — CID 158963062

IUPACbis(2-methyl-4-[5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole);4-[4-[3-[2-(1-methylpiperidin-4-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-(trifluoromethyl)-1,3-thiazole;bis(4-[4-[3-(1,3-thiazol-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)
SMILESCN1CCC(c2nc(-c3c[nH]c4ncc(C5CCC(N6CCOCC6)CC5)cc34)cs2)CC1.Cc1nc(-c2c[nH]c3ncc(C4CCC(N5CCN(C)CC5)CC4)cc23)cs1.Cc1nc(-c2c[nH]c3ncc(C4CCC(N5CCN(C)CC5)CC4)cc23)cs1.FC(F)(F)c1csc(-c2c[nH]c3ncc(C4CCC(N5CCCC5)CC4)cc23)n1.c1csc(-c2c[nH]c3ncc(C4CCC(N5CCOCC5)CC4)cc23)n1.c1csc(-c2c[nH]c3ncc(C4CCC(N5CCOCC5)CC4)cc23)n1
InChIInChI=1S/C26H35N5OS.2C22H29N5S.C21H23F3N4S.2C20H24N4OS/c1-30-8-6-19(7-9-30)26-29-24(17-33-26)23-16-28-25-22(23)14-20(15-27-25)18-2-4-21(5-3-18)31-10-12-32-13-11-31;2*1-15-25-21(14-28-15)20-13-24-22-19(20)11-17(12-23-22)16-3-5-18(6-4-16)27-9-7-26(2)8-10-27;22-21(23,24)18-12-29-20(27-18)17-11-26-19-16(17)9-14(10-25-19)13-3-5-15(6-4-13)28-7-1-2-8-28;2*1-3-16(24-6-8-25-9-7-24)4-2-14(1)15-11-17-18(20-21-5-10-26-20)13-23-19(17)22-12-15/h14-19,21H,2-13H2,1H3,(H,27,28);2*11-14,16,18H,3-10H2,1-2H3,(H,23,24);9-13,15H,1-8H2,(H,25,26);2*5,10-14,16H,1-4,6-9H2,(H,22,23)
InChIKeyJMVZZQYZFHVKHJ-UHFFFAOYSA-N
MW2414.33 g/mol
LogP27.31
Rot. Bonds19

About bis(2-methyl-4-[5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole);4-[4-[3-[2-(1-methylpiperidin-4-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-(trifluoromethyl)-1,3-thiazole;bis(4-[4-[3-(1,3-thiazol-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)

bis(2-methyl-4-[5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole);4-[4-[3-[2-(1-methylpiperidin-4-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-(trifluoromethyl)-1,3-thiazole;bis(4-[4-[3-(1,3-thiazol-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine) (PubChem CID 158963062) has the molecular formula C131H164F3N27O3S6 and a molecular weight of 2414.33 g/mol. Its IUPAC name is bis(2-methyl-4-[5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole);4-[4-[3-[2-(1-methylpiperidin-4-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-(trifluoromethyl)-1,3-thiazole;bis(4-[4-[3-(1,3-thiazol-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine).

Molecular Properties

Compound Namebis(2-methyl-4-[5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole);4-[4-[3-[2-(1-methylpiperidin-4-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-(trifluoromethyl)-1,3-thiazole;bis(4-[4-[3-(1,3-thiazol-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)
PubChem CID158963062
Molecular FormulaC131H164F3N27O3S6
Molecular Weight2414.33 g/mol
Exact Mass2412.18
IUPAC Namebis(2-methyl-4-[5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole);4-[4-[3-[2-(1-methylpiperidin-4-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-(trifluoromethyl)-1,3-thiazole;bis(4-[4-[3-(1,3-thiazol-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)
SMILESCN1CCC(c2nc(-c3c[nH]c4ncc(C5CCC(N6CCOCC6)CC5)cc34)cs2)CC1.Cc1nc(-c2c[nH]c3ncc(C4CCC(N5CCN(C)CC5)CC4)cc23)cs1.Cc1nc(-c2c[nH]c3ncc(C4CCC(N5CCN(C)CC5)CC4)cc23)cs1.FC(F)(F)c1csc(-c2c[nH]c3ncc(C4CCC(N5CCCC5)CC4)cc23)n1.c1csc(-c2c[nH]c3ncc(C4CCC(N5CCOCC5)CC4)cc23)n1.c1csc(-c2c[nH]c3ncc(C4CCC(N5CCOCC5)CC4)cc23)n1
InChIInChI=1S/C26H35N5OS.2C22H29N5S.C21H23F3N4S.2C20H24N4OS/c1-30-8-6-19(7-9-30)26-29-24(17-33-26)23-16-28-25-22(23)14-20(15-27-25)18-2-4-21(5-3-18)31-10-12-32-13-11-31;2*1-15-25-21(14-28-15)20-13-24-22-19(20)11-17(12-23-22)16-3-5-18(6-4-16)27-9-7-26(2)8-10-27;22-21(23,24)18-12-29-20(27-18)17-11-26-19-16(17)9-14(10-25-19)13-3-5-15(6-4-13)28-7-1-2-8-28;2*1-3-16(24-6-8-25-9-7-24)4-2-14(1)15-11-17-18(20-21-5-10-26-20)13-23-19(17)22-12-15/h14-19,21H,2-13H2,1H3,(H,27,28);2*11-14,16,18H,3-10H2,1-2H3,(H,23,24);9-13,15H,1-8H2,(H,25,26);2*5,10-14,16H,1-4,6-9H2,(H,22,23)
InChIKeyJMVZZQYZFHVKHJ-UHFFFAOYSA-N
XLogP27.31
TPSA306.27 Ų
H-Bond Donors6
H-Bond Acceptors30
Rotatable Bonds19
Heavy Atoms170
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002414.33
LogP ≤ 527.31
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1030

Analyze bis(2-methyl-4-[5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole);4-[4-[3-[2-(1-methylpiperidin-4-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-(trifluoromethyl)-1,3-thiazole;bis(4-[4-[3-(1,3-thiazol-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of bis(2-methyl-4-[5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole);4-[4-[3-[2-(1-methylpiperidin-4-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-(trifluoromethyl)-1,3-thiazole;bis(4-[4-[3-(1,3-thiazol-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)?
The IUPAC name of bis(2-methyl-4-[5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole);4-[4-[3-[2-(1-methylpiperidin-4-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-(trifluoromethyl)-1,3-thiazole;bis(4-[4-[3-(1,3-thiazol-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine) (CID 158963062) is bis(2-methyl-4-[5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole);4-[4-[3-[2-(1-methylpiperidin-4-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-(trifluoromethyl)-1,3-thiazole;bis(4-[4-[3-(1,3-thiazol-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine).
What is the SMILES notation for bis(2-methyl-4-[5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole);4-[4-[3-[2-(1-methylpiperidin-4-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-(trifluoromethyl)-1,3-thiazole;bis(4-[4-[3-(1,3-thiazol-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)?
The canonical SMILES for bis(2-methyl-4-[5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole);4-[4-[3-[2-(1-methylpiperidin-4-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-(trifluoromethyl)-1,3-thiazole;bis(4-[4-[3-(1,3-thiazol-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine) is CN1CCC(c2nc(-c3c[nH]c4ncc(C5CCC(N6CCOCC6)CC5)cc34)cs2)CC1.Cc1nc(-c2c[nH]c3ncc(C4CCC(N5CCN(C)CC5)CC4)cc23)cs1.Cc1nc(-c2c[nH]c3ncc(C4CCC(N5CCN(C)CC5)CC4)cc23)cs1.FC(F)(F)c1csc(-c2c[nH]c3ncc(C4CCC(N5CCCC5)CC4)cc23)n1.c1csc(-c2c[nH]c3ncc(C4CCC(N5CCOCC5)CC4)cc23)n1.c1csc(-c2c[nH]c3ncc(C4CCC(N5CCOCC5)CC4)cc23)n1.
What is the InChIKey of bis(2-methyl-4-[5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole);4-[4-[3-[2-(1-methylpiperidin-4-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-(trifluoromethyl)-1,3-thiazole;bis(4-[4-[3-(1,3-thiazol-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)?
The InChIKey is JMVZZQYZFHVKHJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H35N5OS.2C22H29N5S.C21H23F3N4S.2C20H24N4OS/c1-30-8-6-19(7-9-30)26-29-24(17-33-26)23-16-28-25-22(23)14-20(15-27-25)18-2-4-21(5-3-18)31-10-12-32-13-11-31;2*1-15-25-21(14-28-15)20-13-24-22-19(20)11-17(12-23-22)16-3-5-18(6-4-16)27-9-7-26(2)8-10-27;22-21(23,24)18-12-29-20(27-18)17-11-26-19-16(17)9-14(10-25-19)13-3-5-15(6-4-13)28-7-1-2-8-28;2*1-3-16(24-6-8-25-9-7-24)4-2-14(1)15-11-17-18(20-21-5-10-26-20)13-23-19(17)22-12-15/h14-19,21H,2-13H2,1H3,(H,27,28);2*11-14,16,18H,3-10H2,1-2H3,(H,23,24);9-13,15H,1-8H2,(H,25,26);2*5,10-14,16H,1-4,6-9H2,(H,22,23).
What are the key properties of bis(2-methyl-4-[5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole);4-[4-[3-[2-(1-methylpiperidin-4-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-(trifluoromethyl)-1,3-thiazole;bis(4-[4-[3-(1,3-thiazol-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine)?
bis(2-methyl-4-[5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole);4-[4-[3-[2-(1-methylpiperidin-4-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-(trifluoromethyl)-1,3-thiazole;bis(4-[4-[3-(1,3-thiazol-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine) has a molecular weight of 2414.33 g/mol, XLogP of 27.31, 19 rotatable bonds, 6 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for bis(2-methyl-4-[5-[4-(4-methylpiperazin-1-yl)cyclohexyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-1,3-thiazole);4-[4-[3-[2-(1-methylpiperidin-4-yl)-1,3-thiazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine;2-[5-(4-pyrrolidin-1-ylcyclohexyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-(trifluoromethyl)-1,3-thiazole;bis(4-[4-[3-(1,3-thiazol-2-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]cyclohexyl]morpholine) is sourced from PubChem (CID 158963062), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).